Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AADAT | Q8N5Z0 | 2/20 | 0.38 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 3/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | HTR5A | P47898 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2569128 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL31453975 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL30686750 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL29103302 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL1735274 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL29478339 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL30144804 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL31186259 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL2923220 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 | |
| SCHEMBL27115616 | 1.00 | ACHE (0.41) | ACHEAADATTRPM5CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055048-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | BAYER AG (DE) | 2026-02-26 | — | — | US | claimed |
| US-20250382272-A1 | CRYSTALLINE FORM OF INDAZIFLAM, METHODS FOR ITS PREPARATION AND USE THEREOF | ADAMA AGAN LTD. (IL) | 2025-12-18 | — | — | US | claimed |
| WO-2024041962-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | BAYER AKTIENGESELLSCHAFT (DE) | 2024-02-29 | — | — | WO | claimed |
| EP-4722192-A1 | PROCESS FOR THE PREPARATION OF AMIDE INTERMEDIATES | Adama Agan Ltd. (IL) | 2026-04-08 | — | — | EP | disclosed |
| US-20260055048-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | BAYER AG (DE) | 2026-02-26 | — | — | US | disclosed |
| US-20260055048-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | BAYER AG (DE) | 2026-02-26 | — | — | US | disclosed |
| US-20250382272-A1 | CRYSTALLINE FORM OF INDAZIFLAM, METHODS FOR ITS PREPARATION AND USE THEREOF | ADAMA AGAN LTD. (IL) | 2025-12-18 | — | — | US | disclosed |
| EP-4577666-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | Bayer Aktiengesellschaft (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-4393910-A1 | PROCESS FOR THE PREPARATION OF BIGUANIDINE AND TRIAZINES | Adama Agan Ltd. (IL) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024041961-A3 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024041961-A2 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE | BAYER AKTIENGESELLSCHAFT (DE) | 2024-02-29 | — | — | WO | disclosed |
| EP-2231679-A1 | SYNTHESIS OF BIGUANIDINES AND TRIAZINES, AND BIGUANIDINO-ALUMINIUM COMPLEXES AS INTERMEDIATES | Bayer CropScience AG (DE) | 2010-09-29 | — | — | EP | disclosed |
| EP-2210879-A1 | Pyrimidine derivatives and use thereof for combating undesired plant growth | Bayer CropScience AG (DE) | 2010-07-28 | — | — | EP | disclosed |
| EP-2206703-A1 | Pyrimidine derivatives and use thereof for combating undesired plant growth | Bayer CropScience AG (DE) | 2010-07-14 | — | — | EP | disclosed |
| WO-2010076010-A1 | PYRIMIDINE DERIVATIVES AND THE USE THEREOF FOR COMBATING UNDESIRED PLANT GROWTH | BAYER CROPSCIENCE AG (DE) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010076009-A1 | PYRIMIDINE DERIVATIVES AND THE USE THEREOF FOR COMBATING UNDESIRED PLANT GROWTH | BAYER CROPSCIENCE AG (DE) | 2010-07-08 | — | — | WO | disclosed |
| US-20100167935-A1 | Pyrimidine derivatives and their use for controlling undesired plant growth | BAYER CROPSCIENCE AG (DE) | 2010-07-01 | — | — | US | disclosed |
| US-20100167934-A1 | PYRIMIDINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | BAYER CROPSCIENCE AG (DE) | 2010-07-01 | — | — | US | disclosed |
| WO-2009077059-A1 | SYNTHESIS OF BIGUANIDINES AND TRIAZINES, AND BIGUANIDINO-ALUMINIUM COMPLEXES AS INTERMEDIATES | BAYER CROPSCIENCE AG (DE) | 2009-06-25 | — | — | WO | disclosed |
| EP-2070934-A1 | Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates | Bayer CropScience AG (DE) | 2009-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055048-A1 | PROCESS FOR THE PRODUCTION OF (1R,2S)-2,6-DIMETHYL-1-INDANAMINE USING DYNAMIC KINETIC STEREOISOMER RESOLUTION | EMG1, JMJD6, RNGTT | ACHE 340/4885AADAT 737/4885TRPM5 3937/4885 |
| US-20100167935-A1 | Pyrimidine derivatives and their use for controlling undesired plant growth | TYMS, TYMP, UMPS | ACHE 3418/4885AADAT 546/4885TRPM5 4468/4885 |
| US-20100167934-A1 | PYRIMIDINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | TYMS, TYMP, UMPS | ACHE 3054/4885AADAT 579/4885TRPM5 4314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.